Table 2.
Univariate Analysis HR (%95CI) p-value | Multivariate Analysis HR (%95 CI) p- value | |||
---|---|---|---|---|
HER2-0 vs HER2 low | 1.04 (0.69–1.56) | 0.85 | ||
Ki67<%20 vs Ki67>%20 | 1.35 (0.86–2.11) | 0.19 | ||
Grade 1–2 vs Grade 3 | 1.80 (1.12–2.88) | 0.014 | 1.49 (0.92–2.41) | 0.10 |
De novo vs recurren disease | 0.68 (.46–1.01) | 0.057 | ||
Visceral met vs non visceral met | 3.20 (1.98–5.18) | <0.001 | 2.70 (1.62–4.52) | <0.001 |
First-line treatment vs subsequent lines treatment | 0.50 (0.33–.74) | 0.001 | 1.76 (1.10–2.82) | 0.017 |
AI vs Fulvestrant | 1.70 (1.16–2.51) | 0.007 | 1.47 (0.92–2.33) | 0.09 |
HR:hazard ratio, CI:confidence interval.